UBS Group’s Applied UV, Inc. Common Stock AUVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-52
Closed -$5.71K 10084
2023
Q1
$5.71K Buy
52
+44
+550% +$5.84K ﹤0.01% 8000
2022
Q4
$905 Sell
8
-27
-77% -$3.51K ﹤0.01% 10040
2022
Q3
$6K Buy
35
+16
+84% +$3.6K ﹤0.01% 9116
2022
Q2
$6K Sell
19
-4
-17% -$770 ﹤0.01% 8766
2022
Q1
$4K Sell
23
-28
-55% -$6.25K ﹤0.01% 9364
2021
Q4
$17K Buy
51
+23
+82% +$14.3K ﹤0.01% 8098
2021
Q3
$25K Buy
28
+25
+833% +$24K ﹤0.01% 6938
2021
Q2
$4K Sell
3
-22
-88% -$25.5K ﹤0.01% 8722
2021
Q1
$31K Buy
25
+8
+47% +$8.15K ﹤0.01% 6996
2020
Q4
$10K Buy
17
+1
+6% +$725 ﹤0.01% 7515
2020
Q3
$14K Buy
+16
New +$14.2K ﹤0.01% 6604

Other funds holding AUVI

UBS Group's AUVI Position: Q2 2023 in Review

UBS Group sold out of Applied UV, Inc. Common Stock (AUVI) in Q2 2023, closing a stake of 52 shares — an estimated $5.71K sold.

UBS Group first reported a position in AUVI in Q3 2020 and held it in 11 quarters. The position peaked at $31K in Q1 2021. 9 funds tracked by Wall St. Rank hold AUVI as of Q2 2023.

  • UBS Group reported no remaining Applied UV, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • UBS Group sold 52 Applied UV, Inc. Common Stock shares in Q2 2023, an estimated $5.71K.
  • UBS Group first reported a position in Applied UV, Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • UBS Group's Applied UV, Inc. Common Stock position peaked at $31K in Q1 2021.
  • 9 funds tracked by Wall St. Rank held Applied UV, Inc. Common Stock as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.